Cargando…
Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases
OBJECTIVE: To determine plasma apolipoprotein M (apoM) levels and other lipid profiles in hepatocellular carcinoma (HCC) patients compared to other chronic liver diseases and normal subjects. MATERIALS AND METHODS: 36 HCC, 68 chronic hepatitis, 29 liver cirrhosis patients and 64 normal controls were...
Autores principales: | Jiang, Jingting, Zhang, Xiaoying, Wu, Changping, Qin, Xihu, Luo, Guanghua, Deng, Haifeng, Lu, Minyang, Xu, Bin, Li, Min, Ji, Mei, Xu, Ning |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503980/ https://www.ncbi.nlm.nih.gov/pubmed/18652652 http://dx.doi.org/10.1186/1476-511X-7-25 |
Ejemplares similares
-
The FoxOs are in the ApoM house
por: Linton, MacRae F., et al.
Publicado: (2022) -
Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide-induced acute inflammatory apoM(−/−) mice
por: Shi, Yuanping, et al.
Publicado: (2020) -
Non-negligible factors in studying the ApoM-S1P axis using EA.hy926 cells
por: Shi, Yuanping, et al.
Publicado: (2020) -
Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver
por: Luo, Guanghua, et al.
Publicado: (2014) -
A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
por: Hajny, Stefan, et al.
Publicado: (2017)